Document is current
Any future updates will be listed below
-
Authors
Cheng, Ya-Wen
Yang, Ling-Yu
Chen, Yi-Tzu
Chou, Sheng-Che
Chen, Kuo-Wei
Chen, Yi-Hsing
Deng, Chuan-Rou
Chen, I-Chin
Chou, Wan-Ju
Chang, Chen-Chih
Chen, Yong-Ren
Hwa, Hsiao-Lin
Wang, Kuo-Chuan
Kuo, Meng-Fai https://orcid.org/0000-0002-1803-2719
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (108-2314-B-002-086, 109-2314-B-002-124, 110-2314-B-002-160-MY2, 112-2314-B-002-240, 108-2314-B-002-085-MY2, 110-2314-B-002-159, 111-2314-B-002-254-MY2)
National Taiwan University (NTU-NFG-113L7469)
- License Information
-
More Information
Article History
Received: 25 May 2024
Accepted: 26 October 2024
First Online: 14 November 2024
Declarations
:
: This animal experiments were conducted in accordance with the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) and was approved by the Institutional Animal Care and Use Committee of National Taiwan University (Approval no. IACUC-20180430, date of approval: 08/01/2019). The EPCs were collected from fresh human umbilical cord blood and was approved by the Institutional Review Board of National Taiwan University Hospital, Taipei, Taiwan (Study title: Platform establishment, validation, and biomarkers study in cerebrovascular diseases: using pediatric moyamoya disease as a pilot. Approval no. IRB-201204074RIC, date of approval: 07/04/2012; Study title: The pathophysiology of indirect revascularization in chronic cerebral ischemia-induced tauopathy: an in vitro, in vivo and clinical study. Approval no. IRB-202012174RIND, date of approval: 01/19/2021). All patients gave written informed consent for participation in the study and the use of samples.
: All the authors approved this manuscript to be published in the Journal <i>Stem Cell Research & Therapy.</i>
: The authors declare no competing interests.
